Reasons Lilly Remains a Buy: 3 Strong Drivers for Investors
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
Which Index Funds Turn Over Least
If you want minimal turnover, this guide highlights index funds with the least turnover and how to assess them for your portfolio.
27,312 articles
Google Stock Down Double: Buffett's Calm on Alphabet
A sharp drop in Alphabet shares doesn’t erase its long-term potential. This guide explains why Buffett’s approach and...
Netflix Just Reported Earnings: Is the Stock a Buy Now
When Netflix just reported earnings, the market focused on growth signals, margins, and the path to free cash flow. T...
Stock Market Today, Feb.: Novo Nordisk Vivtex Pact
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
Oil Went Over $100 Again as Hormuz Uncertainty Deepens
Oil surged past the $100 mark again on March 12, 2026, after the U.S. signaled limits to protecting the Strait of Hor...
Patriot Financial Partners Makes Major TowneBank Investment
A notable stake in TowneBank marks a strategic bet by Patriot Financial Partners. This article breaks down what the i...
Bridgewater Just Sold Salesforce: A Patient-Stock Debate
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
This Stock Will Dominate the Second Half of 2026, Investors
NovaCore Technologies enters the second half of 2026 with a multi-year backlog, AI revenue momentum, and cloud growth...
World Economic Forum Head Resigns Over Epstein Ties
The world economic forum head Børge Brende resigned Thursday amid scrutiny over ties to Jeffrey Epstein. An independe...
Kinsale Capital Down Here's: Why I’m Still Holding
Kinsale Capital has faced headwinds, but the core business still shows quality underwriting. Here’s why I’m staying i...
U.S. Treasury Will Have to Borrow Over $2 Trillion This Year
Deficits are mounting as the Treasury plots heavy borrowing for the current and next fiscal years. Officials project ...
Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status